2 U.S. lawmakers have disclosed 4 TuHURA Biosciences, Inc. - trades under the STOCK Act — 3 buys and 0 sells between 2024 and 2025. Congress has been net buyers of HURA, and their disclosed buys are down 42.6% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of HURA, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed HURA buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2025-07-13 | Laurel Lee | BUY | $50K–$100K | $2.30 | $2.13 2026-08-27 | -7.4% |
| 2024-11-25 | Laurel Lee | BUY | $1K–$15K | $3.36 | $2.13 2026-08-27 | -36.6% |
| 2024-10-18 | Laurel Lee | exchange | $100K–$250K | $6.30 | $2.13 2026-08-27 | -66.2% |
| 2024-05-06 | Laurel Mrs Lee | BUY | $100K–$250K | $5.08 | $2.13 2026-08-27 | -58.0% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
2 members of the U.S. House and Senate have disclosed TuHURA Biosciences, Inc. - transactions under the STOCK Act — 3 purchases and 0 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a HURA purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed HURA buys are down 42.6% versus the latest close of $2.13. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded HURA and how it performed.